Lee Jung-Kyu, Lee Jinwoo, Park Young Sik, Lee Chang Hoon, Yim Jae-Joon, Yoo Chul-Gyu, Kim Young Whan, Han Sung Koo, Lee Sang-Min
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Korean J Intern Med. 2015 Nov;30(6):829-36. doi: 10.3904/kjim.2015.30.6.829. Epub 2015 Oct 30.
BACKGROUND/AIMS: Whether the causative organism influences the clinical course of pneumonia in the intensive care unit (ICU) is controversial. We assessed the clinical manifestations and prognosis of pneumonia according to the causative pathogens in patients in a medical ICU.
A retrospective observational study was performed in a medical ICU. Among 242 patients who were admitted to the ICU, 103 who were treated for pneumonia were analyzed.
The causative pathogen was identified in 50 patients (49.0%); 22 patients (21.6%) had multidrug-resistant (MDR) pathogens. The distribution of causative micro-organisms was Staphylococcus aureus (20%), Pseudomonas species (16%), Klebsiella pneumoniae (14%), and Acinetobacter baumannii (12%). No significant difference in ICU mortality rate, duration of ICU stay, duration of mechanical ventilation, or frequencies of re-intubation and tracheostomy were detected based on the identification of any pathogen. In sub-analyses according to the pneumonia classification, the number of pathogens identified did not differ between pneumonia types, and a higher incidence of identified MDR pathogens was detected in the hospital-acquired pneumonia group than in the community-acquired or healthcare- acquired pneumonia groups. However, the clinical outcomes of pneumonia according to identification status and type of pathogen did not differ significantly between the groups.
Neither the causative micro-organism nor the existence of MDR pathogens in critically ill patients with pneumonia was associated with the clinical outcome of pneumonia, including ICU mortality. This result was consistent regardless of the pneumonia classification.
背景/目的:在重症监护病房(ICU)中,致病微生物是否会影响肺炎的临床病程仍存在争议。我们根据内科ICU患者的致病病原体评估了肺炎的临床表现和预后。
在内科ICU进行了一项回顾性观察研究。在242例入住ICU的患者中,对103例接受肺炎治疗的患者进行了分析。
50例患者(49.0%)确定了致病病原体;22例患者(21.6%)有多重耐药(MDR)病原体。致病微生物的分布为金黄色葡萄球菌(20%)、假单胞菌属(16%)、肺炎克雷伯菌(14%)和鲍曼不动杆菌(12%)。基于任何病原体的鉴定,在ICU死亡率、ICU住院时间、机械通气时间或再次插管和气管切开频率方面未检测到显著差异。在根据肺炎分类进行的亚分析中,肺炎类型之间鉴定出的病原体数量没有差异,医院获得性肺炎组中鉴定出的MDR病原体发生率高于社区获得性或医疗保健相关性肺炎组。然而,根据病原体鉴定状态和类型,各组之间肺炎的临床结局没有显著差异。
肺炎重症患者的致病微生物和MDR病原体的存在均与肺炎的临床结局(包括ICU死亡率)无关。无论肺炎分类如何,该结果均一致。